Drugs / KQB365
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06720987 | Feb 2025 → Jun 2029 expected | colorectal cancer | Kumquat Biosciences Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KQB365 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06720987 ↗ |
| Route | Intravenous | “Intravenous KQB365” NCT06720987 ↗ |